The Report Guru

The preclinical imaging market is poised for significant growth in the coming years. According to the report “Preclinical Imaging Market size by Product Type (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, Nuclear Imaging Reagents), Application (Oncology, Neurology), End User (Pharmaceutical, Imaging Centers) – Global Forecast to 2029,” the market is expected to reach USD 1,259 million by 2029 from USD 946 million in 2024, at a CAGR of 5.9%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=841 Market Dynamics and Growth Drivers The preclinical imaging market is driven by several factors. Increasing funding for preclinical research is a primary catalyst, alongside the development of cost-effective imaging systems. The rising demand for new drug development and noninvasive small-animal imaging techniques also significantly boosts the market. These factors collectively drive advancements and the adoption of preclinical ...

  The preclinical imaging market is poised for significant growth in the coming years. According to the report " Preclinical Imaging Market size by Product Type (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, Nuclear Imaging Reagents), Application (Oncology, Neurology), End User (Pharmaceutical, Imaging Centers) - Global Forecast to 2029 ," the market is expected to reach USD 1,259 million by 2029 from USD 946 million in 2024, at a CAGR of 5.9%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=841 Market Dynamics and Growth Drivers The preclinical imaging market is driven by several factors. Increasing funding for preclinical research is a primary catalyst, alongside the development of cost-effective imaging systems. The rising demand for new drug development and noninvasive small-animal imaging techniques also significantly boosts the market. These factors collectively drive advancements and the adoption of pr...

According to a new market research report " Preclinical Imaging Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global Forecast 2021" published by MarketsandMarkets, The market is expected to reach USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016 to 2021. Browse 83 market data Tables and 39 Figures spread through 161 Pages and in-depth TOC on "Preclinical Imaging (In-VIVO) Market" Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=841 This report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW) for the forecast period of 2016 to 2021. The market is expected to reach USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016 to 2021. On the bas...

According to research report the preclinical imaging market is expected to reach USD 910.4 Million by 2021, growing at a CAGR of 6.2% during 2016 to 2021. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=841 A number of factors such as the technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches are propelling the growth of the preclinical imaging market. The report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW). On the basis of products, the global preclinical imaging market is divided into two major categories, namely, modalities and reagents. Preclinical imaging modalities market is further divided into seven imaging modalities, namely, optical imaging syst...

According to research report Preclinical Imaging Market is expected to reach USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016 to 2021. The Report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW). Over the last two decades, preclinical imaging has witnessed significant importance in the drug discovery and development. Development of technologically advanced multi-modality preclinical imaging systems and their increased adoption in preclinical research studies acted as driving factor for global preclinical imaging market. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=841 Leading Market Players - The key players in the preclinical imaging market focus on various strategies such as product approvals, launches, and enhancements; geographic expansions; partnerships, agreements, and collaborations; and strategic a...

According to research report the global  Preclinical Imaging Market  is estimated to grow at a CAGR of 6.2% from 2016 to 2021 to reach USD 910.4 Million by 2021. The key players in the Preclinical Molecular Imaging Market focus on various strategies such as product approvals, launches, and enhancements; geographic expansions; partnerships, agreements, and collaborations; and strategic acquisitions in order to increase their market shares in the global Preclinical Molecular Imaging Market. Product approvals, launches, and enhancements was the key strategy adopted by major industry players to achieve growth in the Preclinical Molecular Imaging Market.  Download Brochure :  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=841   This strategy was majorly adopted by PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd. (U.K.), and Aspect Imaging Ltd. (Israel). Apart from product approvals, lau...